MIMS Spotlight Series: Meet Sarah Lundgren

Text written by Nóra Lehotai and Sarah Lundgren. Photo credits: Sarah Lundgren.

Sarah Lundgren joined MIMS in November 2020. She felt like coming home after living in the UK, Australia and Japan and nowadays she enjoys life in Umeå with her partner, Sam, and many more four legged friends. Enjoy the interview with Sarah!

Can you tell us about your role at MIMS, what are you working on now? 

My main responsibility in the Oliver Billker’s lab here at MIMS, is the management of our insectary. We rear mosquito colonies for our malaria research, and I make sure that our scientists have access to mosquitoes for their various experiments. Besides running the insectary, I am also responsible for coordinating the logistics, and making sure that everything runs smoothly.

Read more: MIMS Spotlight Series: Meet Sarah Lundgren

MIMS Spotlight Series: Meet Barbara Forró

Text written by Nóra Lehotai and Barbara Forró. Photo credits: Csaba Guti.

I had a chat with Barbara, who is a postdoctoral fellow in Maria Fällman’s group. After living in Hungary and Canada, she moved to Umeå in August 2020. She shares her home with her husband and “never enough” number of plants.

Can you tell us about your role at MIMS; what are you working on now?

My main project is about shedding light on the molecular mechanism of Salmonella enterica serovar typhimurium invasion and persistence. I am being fortunate to analyze a huge bulk of RNA seq data from an in vivo mice experiment, that would drive us closer to understand the mechanisms of the bacterial persistence in the host and, as always in science, would raise more fascinating questions regarding the topic. Outside of the main project, I am taking the time to learn more about mechanisms of Yersinia pseudotuberculosis invasion and persistence in the host.

Read more: MIMS Spotlight Series: Meet Barbara Forró

UCMR is looking for a research coordinator

 Umeå Centre for Microbial Research (UCMR) is looking for a research coordinator. For more information and application please go to: https://www.umu.se/en/work-with-us/open-positions/research-coordinator_383570/ . Application deadline: April 13, 2021. To find out more about the institute, visit their website at https://www.ucmr.umu.se/ .

Prestigious postdoctoral fellowship for structural biology and infection research in Umeå

Text written by Himanshu Sharma and Nóra Lehotai. Photo: Himanshu Sharma by the Titan Krios cryo-electron microscope at the Umeå Centre for Electron Microscopy (UCEM). Credit: Kai Ehrenbolger. 

Himanshu Sharma, a postdoctoral researcher in Jonas Barandun’s lab at MIMS and the Department of Molecular Biology, Umeå University, got awarded the prestigious Marie Skłodowska-Curie Actions (MSCA) Individual Fellowship, giving him the opportunity to carry out the proposed research project with the financial support of 191 000 € over two years.

“I am exhilarated to have received this research funding. This fellowship gives me an opportunity to investigate the intriguing infection mechanism of microsporidia through cutting-edge methods in structural biology. Microsporidia are a class of obligate parasites that employ unique methods to infect almost all organisms, including bees, fish, farmed animals and humans. Apart from being an enormous environmental and healthcare challenge, these organisms also exhibit a range of evolutionarily distinctive cellular processes. To understand these interesting but understudied pathogens, I am going to combine my existing knowledge in RNA biology with cryo-EM to understand the critical events in the microsporidia lifecycle. Through these advancements, I aim to develop an understanding of potential drug targets to curb the growing menace of microsporidia infections.”- he commented. 

Read more: Prestigious postdoctoral fellowship for structural biology and infection research in Umeå

Identification of a protective protein that reduces the severity of COVID-19

Written by Elin Thysell

Researchers at Umeå University and their international collaborative partners have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings were published on 26th February 2021 in Nature Medicine.

“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains Dr. Elin Thysell, researcher at Medical Biosciences and Deputy Project Manager for PREDICT. PREDICT is the newly launched initiative at the Medical Faculty with the goal of finding tools early that make it possible to prevent or alleviate diseases by developing the use of biobank samples in the healthcare area. “This is a very exciting development in the race to identify potential therapies to treat patients because there are already therapies in pre-clinical development that boost OAS1 and could be explored for their effect against SARS-CoV-2 infection.” says Johan Normark, specialist doctor in infectious diseases at Umeå University Hospital and principal investigator of the CoVUm study. This clinical study for COVID-19, carried out as a collaboration between Region Västerbotten and Umeå University, studies immunity and the course of the disease furthermore, why the disease strikes so hard on certain individuals.

Read more: Identification of a protective protein that reduces the severity of COVID-19